Triage performance of PAX1m/JAM3m in opportunistic cervical cancer screening of non‒16/18 human papillomavirus-positive women: a multicenter prospective study in China

Abstract excerpt

In this study, we aimed to validate the performance of the PAX1 and JAM3 methylation ( PAX1 m / JAM3 m ) test as a triage tool for detecting cervical intraepithelial neoplasia grade 3 or worse (CIN3 +) in non-16/18 high-risk human papillomavirus-positive patients (non-16/18 hrHPV +). The triage performance of liquid-based cytology (LBC) and the PAX1 m / JAM3 m test for detecting CIN3 + were compared. In total,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Genomics and Diagnostics
• Share to Cervical Cancer and HPV Research
• Share to Molecular Biology Techniques and Applications